fda removes tirzepatide from shortage list As of February 21, 2025, the updated its drug list, marking the semaglutide injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Semaglutide shortage ends as FDA

COVERAGE OUTLOOK What's Changing in 2026 2026: Diverging Trends The insurance landscape for Zepbound is splitting: Medicare/Medicaid expanding via new CMS pilot programs while many commercial plans are pulling back

its skin that has been quietly deprived of the materials it needs to maintain itself, he says

Symptoms include shakiness, sweating, confusion, rapid heartbeat, and extreme hunger

Reduces stress level

Multimodal pathway analysis benchmarking We evaluated the performance of SpaMTPs pathway enrichment analysis against existing tools for bulk data (MetaboAnalyst and Ingenuity Pathway Analysis (IPA)) 31,32

beehiiv is where they built it